secwatch.observer — SEC 8-K summary
======================================

Issuer:     Avalo Therapeutics, Inc. (AVTX)
CIK:        0001534120
Form:       8-K
Filed at:   2023-08-07T23:59:59+00:00
Accession:  0001628280-23-027842
Event type: debt
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Avalo Therapeutics increases ATM offering capacity to $50M from $9M
-------------------------------------------------------------------

- Amended Sales Agreement with Oppenheimer ups aggregate offering to $50,000,000.
- As of Aug 4, 2023, had sold ~$8.3M of common stock under prior $9.03M limit.
- Remaining capacity under amended agreement is approximately $41.7M.
- Shares sold via 'at the market' offering under existing registration statement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1534120/000162828023027842/0001628280-23-027842-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1534120/000162828023027842/avtx-20230807.htm
  HTML page:      https://secwatch.observer/filing/0001628280-23-027842

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer